Institutional investors purchased a net $5.3 million shares of NEO during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 46.37% of shares outstanding that institutional investors hold is actually below the Medical/Nursing Services industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GROW PARTNERS LLC Bought 3.8 Million shares of Neogenomics Inc
FIRST LIGHT ASSET MANAGEMENT LLC Bought 1.1 Million shares of Neogenomics Inc